Circulating Biomarker Market Report

Circulating Biomarker Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Mar 17, 2020
  • PAGES：176
  • REPORT CODE：GMM510779
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Circulating Biomarker market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.9% during the forecast period.

    This report presents the market size and development trends by detailing the Circulating Biomarker market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Circulating Biomarker market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Circulating Biomarker industry and will help you to build a panoramic view of the industrial development.

    Circulating Biomarker Market, By Type:

    • Circulating DNA

    • Circulating Tumor Cells

    • Other

    Circulating Biomarker Market, By Application:

    • Hospital

    • Medical Research Center

    • Others

    Some of the leading players are as follows:

    • Biocept

    • Fluxion Biosciences

    • Becton, Dickinson and Company

    • Epigenomics AG

    • Agilent Technologies

    • GE Healthcare

    • Abbott Laboratories

    • Affymetrix

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Circulating Biomarker Market: Technology Type Analysis

    • 4.1 Circulating Biomarker Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Circulating Biomarker Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Circulating DNA

      • 4.3.2 Circulating Tumor Cells

      • 4.3.3 Other

    5 Circulating Biomarker Market: Product Analysis

    • 5.1 Circulating Biomarker Product Market Share Analysis, 2018 & 2026

    • 5.2 Circulating Biomarker Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Circulating Biomarker Market: Application Analysis

    • 6.1 Circulating Biomarker Application Market Share Analysis, 2018 & 2026

    • 6.2 Circulating Biomarker Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Hospital

      • 6.3.2 Medical Research Center

      • 6.3.3 Others

    7 Circulating Biomarker Market: Regional Analysis

    • 7.1 Circulating Biomarker Regional Market Share Analysis, 2018 & 2026

    • 7.2 Circulating Biomarker Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Biocept

      • 9.1.1 Biocept Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Fluxion Biosciences

      • 9.2.1 Fluxion Biosciences Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Becton, Dickinson and Company

      • 9.3.1 Becton, Dickinson and Company Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Epigenomics AG

      • 9.4.1 Epigenomics AG Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Agilent Technologies

      • 9.5.1 Agilent Technologies Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 GE Healthcare

      • 9.6.1 GE Healthcare Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Abbott Laboratories

      • 9.7.1 Abbott Laboratories Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Affymetrix

      • 9.8.1 Affymetrix Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

     

    The List of Tables and Figures (Totals 70 Figures and 131 Tables)

    • Figure Circulating DNA Circulating Biomarker market, 2015 - 2026 (USD Million)

    • Figure Circulating Tumor Cells Circulating Biomarker market, 2015 - 2026 (USD Million)

    • Figure Other Circulating Biomarker market, 2015 - 2026 (USD Million)

    • Figure Hospital market, 2015 - 2026 (USD Million)

    • Figure Medical Research Center market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Circulating Biomarker market, by country, 2015 - 2026 (USD Million)

    • Table North America Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table North America Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table North America Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Canada Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Canada Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Europe Circulating Biomarker market, by country, 2015 - 2026 (USD Million)

    • Table Europe Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Europe Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Europe Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Germany Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Germany Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table France Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table France Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Italy Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Italy Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Spain Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Spain Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Circulating Biomarker market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table China Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table China Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Japan Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Japan Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table India Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table India Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Circulating Biomarker market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table MEA Circulating Biomarker market, by country, 2015 - 2026 (USD Million)

    • Table MEA Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table MEA Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table MEA Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Circulating Biomarker market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Circulating Biomarker market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Circulating Biomarker market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Biocept Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Fluxion Biosciences Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Becton, Dickinson and Company Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Epigenomics AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Agilent Technologies Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GE Healthcare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Affymetrix Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US